The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of circulating tumor DNA (ctDNA) for early assessment of treatment response in patients with advanced colorectal cancer (aCRC): A real-world (RW) analysis.
 
Pashtoon Murtaza Kasi
Consulting or Advisory Role - Bayer; Boston Healthcare Associates; Daiichi Sankyo/Astra Zeneca; Delcath Systems; Eisai; Exact Sciences; Foundation Medicine; Inflecton Point Biomedical Advisors; Ipsen (Inst); Lilly; MSD Oncology; Natera; QED Therapeutics; Seagen; SERVIER; Taiho Oncology; Taiho Pharmaceutical (Inst); Tempus
Research Funding - Advanced Accelerator Applications (Inst); Boston Scientific (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Caroline Weipert
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Tim Nguyen
No Relationships to Disclose
 
Jiemin Liao
Employment - Guardant Health; Roche/Genentech (I)
Stock and Other Ownership Interests - Guardant Health; Roche/Genentech (I)
Research Funding - Guardant Health
 
Nicole Zhang
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Shaun Forbes
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Sean Gordon
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Benjamin R. Tan
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); TYME (Inst)